Literature DB >> 26656977

Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future.

Arash Olyie Naghavi, Peter A S Johnstone, Sungjune Kim.   

Abstract

Cancer immunotherapy is rapidly redefining the standard of cancer care. The role of radiation therapy in eliciting antitumoral immune response is also being actively investigated in combination with various immunotherapeutic agents to exploit potential synergy between the 2 modalities. In this review, we summarize the rationale and results of past and ongoing clinical trials that combined the use of radiation therapy and immunogenic agents such as vaccines, cytokines, immune checkpoint inhibitors, costimulatory agonists, and myeloid activators.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656977     DOI: 10.1016/j.currproblcancer.2015.10.002

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  4 in total

1.  Understanding the pluses of pulses.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Cell Cycle       Date:  2017-06-21       Impact factor: 4.534

Review 2.  The changing paradigm of tumour response to irradiation.

Authors:  Richard P Hill
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

Review 3.  Breast Cancer Immunotherapy: An Update.

Authors:  Issam Makhoul; Mohammad Atiq; Ahmed Alwbari; Thomas Kieber-Emmons
Journal:  Breast Cancer (Auckl)       Date:  2018-05-30

4.  Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging.

Authors:  Ahmed Salem; Hitesh Mistry; Alison Backen; Clare Hodgson; Pek Koh; Emma Dean; Lynsey Priest; Kate Haslett; Ioannis Trigonis; Alan Jackson; Marie-Claude Asselin; Caroline Dive; Andrew Renehan; Corinne Faivre-Finn; Fiona Blackhall
Journal:  Clin Lung Cancer       Date:  2017-12-11       Impact factor: 4.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.